IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes

Molecular and Cellular Biology

Volumn 34, Issue 6, 2014, Pages 1054-1065

  Sgarbanti, Marco ^a   Marsili, Giulia ^a   Remoli, Anna Lisa ^a   Stellacci, Emilia ^a   Mai, Antonello ^b   Rotili, Dante ^b   Perrotti, Edvige ^a   Acchioni, Chiara ^a   Orsatti, Roberto ^a   Iraci, Nunzio ^c   Ferrari, Mathieu ^a   Borsetti, Alessandra ^a   Hiscott, John ^d   Battistini, Angela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; LYMPHOCYTE ACTIVATION; P300-CBP TRANSCRIPTION FACTORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84894284462     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01161-13     Document Type: Article

References (46)

1. Honda K, Takaoka A, Taniguchi T. 2006. Type I inteferon [sic] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349-360. http://dx.doi.org/10.1016/j.immuni.2006.08.009.
2. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655. http://dx.doi.org/10.1146/annurev.immunol.19.1.623.
3. Nomura F, Kawai T, Nakanishi K, Akira S. 2000. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells 5:191-202. http://dx.doi.org/10.1046/j.1365-2443.2000.00315.x.
4. Rothgiesser KM, Fey M, Hottiger MO. 2010. Acetylation of p65 at lysine 314 is important for late NF-kappaB-dependent gene expression. BMC Genomics 11:22. http://dx.doi.org/10.1186/1471-2164-11-22.
5. Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA. 2000. Viral activation of interleukin-15 (IL-15): characterization of a virusinducible element in the IL-15 promoter region. J. Virol. 74:7338-7348. http://dx.doi.org/10.1128/JVI.74.16.7338-7348.2000.
6. Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K. 1995. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1037-1045.
7. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558-2569.
8. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ. 1999. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J. Mol. Biol. 289:459-471. http://dx.doi.org/10.1006/jmbi.1999.2752.
9. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, Marsili G, Marziali G, Coccia EM, Ensoli B, Battistini A. 2002. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J. Exp. Med. 195:1359-1370. http://dx.doi.org/10.1084/jem.20010753.
10. Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A. 2008. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J. Virol. 82:3632-3641. http://dx.doi.org/10.1128/JVI.00599-07.
11. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816-818. http://dx.doi.org/10.1038/382816a0.
12. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535-584. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090400.
13. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, Mak TW. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681-689. http://dx.doi.org/10.1016/S1074-7613(00)80444-6.
14. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M, Shin EH, Kojima S, Taniguchi T, Asano Y. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-679. http://dx.doi.org/10.1016/S1074-7613(00)80443-4.
15. Merika M, Thanos D. 2001. Enhanceosomes. Curr. Opin. Genet. Dev. 11:205-208. http://dx.doi.org/10.1016/S0959-437X(00)00180-5.
16. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103:667-678. http://dx.doi.org/10.1016/S0092-8674(00)00169-0.
17. Ford E, Thanos D. 2010. The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta 1799:328-336. http://dx.doi.org/10.1016/j.bbagrm.2010.01.010.
18. Chen LF, Greene WC. 2003. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81:549-557. http://dx.doi.org/10.1007/s00109-003-0469-0.
19. Chen LF, Mu Y, Greene WC. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21:6539-6548. http://dx.doi.org/10.1093/emboj/cdf660.
20. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M. 2003. Post-activation turn-off of NFkappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758-2766. http://dx.doi.org/10.1074/jbc.M209572200.
21. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http://dx.doi.org/10.1016/S1074-7613(00)00053-4.
22. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. http://dx.doi.org/10.1038/nature03464.
23. Masumi A, Wang IM, Lefebvre B, Yang XJ, Nakatani Y, Ozato K. 1999. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol. 19:1810-1820.
24. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
25. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. http://dx.doi.org/10.1038/ni921.
26. Shen RR, Hahn WC. 2011. Emerging roles for the non-canonical IKKs in cancer. Oncogene 30:631-641. http://dx.doi.org/10.1038/onc.2010.493.
27. Hutti JE, Shen RR, Abbott DW, Zhou AY, Sprott KM, Asara JM, Hahn WC, Cantley LC. 2009. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol. Cell 34:461-472. http://dx.doi.org/10.1016/j.molcel.2009.04.031.
28. Mai A, Rotili D, Tarantino D, Nebbioso A, Castellano S, Sbardella G, Tini M, Altucci L. 2009. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases. Bioorg. Med. Chem. Lett. 19:1132-1135. http://dx.doi.org/10.1016/j.bmcl.2008.12.097.
29. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 11:1357-1362. http://dx.doi.org/10.1093/intimm/11.8.1357.
30. Peters RT, Liao SM, Maniatis T. 2000. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol. Cell 5:513-522. http://dx.doi.org/10.1016/S1097-2765(00)80445-1.
31. Lin R, Mustafa A, Nguyen H, Gewert D, Hiscott J. 1994. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. J. Biol. Chem. 269:17542-17549.
32. Sgarbanti M, Arguello M, tenOever BR, Battistini A, Lin R, Hiscott J. 2004. A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene 23:5770-5780. http://dx.doi.org/10.1038/sj.onc.1207707.
33. tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, Julkunen I, Hemmi H, Yamamoto M, Akira S, Yeh WC, Lin R, Hiscott J. 2004. Activation of TBK1 and IKKepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78:10636-10649. http://dx.doi.org/10.1128/JVI.78.19.10636-10649.2004.
34. Clark K, Plater L, Peggie M, Cohen P. 2009. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284:14136-14146. http://dx.doi.org/10.1074/jbc.M109.000414.
35. Li C, Ma L, Chen X. 2011. Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3. Cell. Mol. Immunol. 8:67-74. http://dx.doi.org/10.1038/cmi.2010.55.
36. Kreegipuu A, Blom N, Brunak S. 1999. PhosphoBase, a database of phosphorylation sites: release 2.0. Nucleic Acids Res. 27:237-239. http://dx.doi.org/10.1093/nar/27.1.237.
37. Paz S, Sun Q, Nakhaei P, Romieu-Mourez R, Goubau D, Julkunen I, Lin R, Hiscott J. 2006. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell. Mol. Biol. (Noisy-le-Grand) 52:17-28. http://dx.doi.org/10.1170/T694.
38. Merika M, Williams AJ, Chen G, Collins T, Thanos D. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1:277-287. http://dx.doi.org/10.1016/S1097-2765(00)80028-3.
39. Dornan D, Eckert M, Wallace M, Shimizu H, Ramsay E, Hupp TR, Ball KL. 2004. Interferon regulatory factor 1 binding to p300 stimulates DNAdependent acetylation of p53. Mol. Cell. Biol. 24:10083-10098. http://dx.doi.org/10.1128/MCB.24.22.10083-10098.2004.
40. Giroux M, Schmidt M, Descoteaux A. 2003. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J. Immunol. 171:4187-4194. http://www.jimmunol.org/content/171/8/4187.long.
41. Lin R, Hiscott J. 1999. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol. Cell. Biochem. 191:169-180. http://dx.doi.org/10.1023/A:1006850009017.
42. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, Takayanagi H, Ohba Y, Taniguchi T, Honda K. 2006. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. U. S. A. 103:15136-15141. http://dx.doi.org/10.1073/pnas.0607181103.
43. Brasier AR, Tian B, Jamaluddin M, Kalita MK, Garofalo RP, Lu M. 2011. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J. Virol. 85:11752-11769. http://dx.doi.org/10.1128/JVI.05360-11.
44. Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. 2009. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29:1375-1387. http://dx.doi.org/10.1128/MCB.01365-08.
45. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. 2004. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 279:45194-45207. http://dx.doi.org/10.1074/jbc.M400726200.
46. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249. http://dx.doi.org/10.1038/nature03308.